Nonredundant Roles for Leukotriene B4 Receptors BLT1 and BLT2 in Inflammatory Arthritis
Open Access
- 1 September 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 185 (5) , 3049-3056
Abstract
Lipid mediators derived from arachidonic acid through the cyclooxygenase and lipoxygenase pathways are known to be important mediators of inflammation. Studies in mouse models demonstrated an important role for the high-affinity leukotriene B4 receptor BLT1 in arthritis, atherosclerosis, and asthma. BLT2, a low-affinity leukotriene B4 receptor, was also shown to be a high-affinity receptor for cyclooxygenase-1 derived 12(S)-hydroxyheptadeca-5Z, 8E, 10E-trienoic acid. However, its biochemical activities and physiological roles remain unknown. In this study, we developed mice deficient in BLT2 by targeted disruption. The BLT2−/− mice developed normally, and analysis of immune cells showed that disruption of BLT2 did not alter BLT1 expression or function. Mast cells from the C57BL/6 mice but not from the BLT2−/− mice showed intracellular calcium mobilization in response to 12(S)-hydroxyheptadeca-5Z, 8E, 10E-trienoic acid. In an autoantibody-induced inflammatory arthritis model, the BLT2−/− mice showed reduced incidence and severity of disease, including protection from bone and cartilage loss. Reciprocal bone marrow transplant experiments identified that loss of BLT2 expression on a bone marrow-derived cell lineage offers protection against severe disease. Thus, BLT2, a unique receptor for 5-lipoxygenase– and cyclooxygenase-1–derived lipid mediators, represents a novel target for therapies directed at treating inflammation associated with arthritis.Keywords
This publication has 75 references indexed in Scilit:
- Platelets Amplify Inflammation in Arthritis via Collagen-Dependent Microparticle ProductionScience, 2010
- 12(S)-hydroxyheptadeca-5Z, 8E, 10E–trienoic acid is a natural ligand for leukotriene B4 receptor 2Journal of Experimental Medicine, 2008
- Clinical trial of a leucotriene B4 receptor antagonist, BIIL 284, in patients with rheumatoid arthritisAnnals of the Rheumatic Diseases, 2007
- Role of leukotriene B4 receptors in rheumatoid arthritisAutoimmunity Reviews, 2007
- Regulation of dendritic cell migration and adaptive immune response by leukotriene B4 receptors: a role for LTB4 in up-regulation of CCR7 expression and functionBlood, 2006
- Differential induction of BLT receptor expression on human endothelial cells by lipopolysacharide, cytokines, and leukotriene B4Proceedings of the National Academy of Sciences, 2006
- Leukotriene B4 receptorsProstaglandins & Other Lipid Mediators, 2002
- Hydroxyeicosanoids Bind to and Activate the Low Affinity Leukotriene B4 Receptor, BLT2Journal of Biological Chemistry, 2001
- Molecular cloning and characterization of another leukotriene B4 receptorJournal of Biological Chemistry, 2000
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988